微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Aerpio Pharm (ARPO) +63.16%
GBS Inc (GBS) +33.22%
Alterity Therapeutics (ATHE) +27.85%
9 Meters Biopharma (NMTR) +20.39%
F-star Therapeutics (FSTX) +9.13%
Los...查看全文
$Nephros(NEPH)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001493152-22-001104 Act: 34 Size: 285 KB 网页链接
$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-028832 Size: 16 KB 网页链接
$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-028833 Size: 7 KB 网页链接
$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-028834 Size: 11 KB 网页链接
$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-028835 Size: 10 KB 网页链接
$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-028836 Size: 10 KB 网页链接
$Nephros(NEPH)$ 8-K Current report, items 4.01 and 9.01 Accession Number: 0001493152-21-030449 Act: 34 Size: 213 KB 网页链接
$Nephros(NEPH)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001493152-21-027249 Act: 34 Size: 6 MB 网页链接
$Nephros(NEPH)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001493152-21-025001 Act: 34 Size: 238 KB 网页链接
$Nephros(NEPH)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001493152-21-022776 Act: 33 Size: 190 KB 网页链接